Lung cancer and lung transplantation: A review

Journal of Thoracic Oncology

Volumn 4, Issue 6, 2009, Pages 753-760

  Mathew, Josy ^a   Kratzke, Robert A ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bronchioalveolar cancer; Lung transplantation; NSCLC

Indexed keywords

ANTINEOPLASTIC AGENT; BASILIXIMAB; RAPAMYCIN;

ADJUVANT THERAPY; BREAST CANCER; CHRONIC GRAFT REJECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DONOR; DRUG SUBSTITUTION; EMPHYSEMA; FIBROSING ALVEOLITIS; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT INDICATION; LUNG TUMOR; REVIEW;

HUMANS; LUNG NEOPLASMS; LUNG TRANSPLANTATION;

EID: 67849094532     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31819afdd9     Document Type: Review

References (73)

1. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140-1145. (Pubitemid 16138660)
2. International Society for Heart and Lung Transplantation. International Heart/Lung Transplant Registry. Available at: http://www.ishlt.org/registries/ heartLungRegistry.asp. Accessed May 1, 2007.
3. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000;23:101-113.
4. Ma Y, Seneviratne CK, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin Pulm Med 2001;7:278-282. (Pubitemid 32929682)
5. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-437. (Pubitemid 41291088)
6. Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002;121:1278-1289. (Pubitemid 34280454)
7. Harris JM, Cullinan P, McDonald JC. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer? J Epidemiol Community Health 1998;52:602-603. (Pubitemid 28416802)
8. Wells C, Mannino DM. Pulmonary fibrosis and lung cancer in the united states: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J 1996;89:505-510. (Pubitemid 26142552)
9. Spiekerkoetter E, Krug N, Hoeper M, et al. Prevalence of malignancies after lung transplantation. Transplant Proc 1998;30:1523-1524. (Pubitemid 28309672)
10. Choi YH, Leung AN, Miro S, Poirier C, Hunt S, Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000;15:36-40. (Pubitemid 30022855)
11. Arcasoy SM, Hersh C, Christie JD, et al. Bronchogenic carcinomacomplicating lung transplantation. J Heart Lung Transplant 2001;20: 1044-1053.
12. de Perrot M, Wigle DA, Pierre AF, et al. Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003;75:367-371. (Pubitemid 36184472)
13. Collins J, Kazerooni EA, Lacomis J, et al. Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. Radiology 2002;224:131-138. (Pubitemid 34685511)
14. Dickson RP, Davis RD, Rea JB, Palmer SM. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006;25:1297-1301.
15. Mulligan MS, Shearon TH, Weill D, Pagani FD, Moore J, Murray S. Heart and lung transplantation in the united states, 1997-2006. Am J Transplant 2008;8:977-987.
16. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the international society for heart and lung transplantation: twenty-second official adult lung and heart-lung transplant report- 2005. J Heart Lung Transplant 2005;24:956-967. (Pubitemid 41127175)
17. Gries CJ, Mulligan MS, Edelman JD, Raghu G, Curtis JR, Goss CH. Lung allocation score for lung transplantation: impact on disease severity and survival. Chest 2007;132:1954-1961.
18. De Perrot M, Waddell TK, Shargall Y, et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007;133: 525-531. (Pubitemid 46136289)
19. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the pulmonary scientific council of the international society for heart and lung transplantation. J Heart Lung Transplant 2006;25:745-755. (Pubitemid 43963375)
20. Svendsen CA, Bengtson RB, Park SJ, Shumway SJ. Stage I adenocarcinoma presenting in the pneumonectomy specimen at the time of single lung transplantation. Transplantation 1998;66:1108-1109.
21. Abrahams NA, Meziane M, Ramalingam P, Mehta A, DeCamp M, Farver CF. Incidence of primary neoplasms in explanted lungs: longterm follow-up from 214 lung transplant patients. Transplant Proc 2004;36:2808-2811. (Pubitemid 40036843)
22. de Perrot M, Fischer S, Waddell TK, et al. Management of lung transplant recipients with bronchogenic carcinoma in the native lung. J Heart Lung Transplant 2003;22:87-89. (Pubitemid 36071421)
23. de Perrot M, Chernenko S, Waddell TK, et al. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease. J Clin Oncol 2004;22:4351-4356. (Pubitemid 41185155)
24. Kazerooni EA, Chow LC, Whyte RI, Martinez FJ, Lynch JP. Preoperative examination of lung transplant candidates: value of chest CT compared with chest radiography. AJR Am J Roentgenol 1995;165: 1343-1348.
25. De Soyza AG, Dark JH, Parums DV, Curtis A, Corris PA. Donoracquired small cell lung cancer following pulmonary transplantation. Chest 2001;120:1030-1031. (Pubitemid 32885484)
26. Beyer EA, DeCamp MM, Smedira NG, Farver C, Mehta A, Warshawsky I. Primary adenocarcinoma in a donor lung: evaluation and surgical management. J Heart Lung Transplant 2003;22:1174-1177. (Pubitemid 37206574)
27. Picard C, Grenet D, Copie-Bergman C, et al. Small-cell lung carcinoma of recipient origin after bilateral lung transplantation for cystic fibrosis. J Heart Lung Transplant 2006;25:981-984. (Pubitemid 44143012)
28. Paloyan EB, Swinnen LJ, Montoya A, Lonchyna V, Sullivan HJ, Garrity E. Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs. Transplantation 2000;69:2446-2448. (Pubitemid 30409020)
29. Garver RI Jr, Zorn GL, Wu X, McGiffin DC, Young KR Jr, Pinkard NB. Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl J Med 1999;340:1071-1074. (Pubitemid 29162511)
30. Zorn GL Jr, McGiffin DC, Young KR Jr, Alexander CB, Weill D, Kirklin JK. Pulmonary transplantation for advanced bronchioloalveolar carcinoma. See comment. J Thorac Cardiovasc Surg 2003;125:45-48. (Pubitemid 36120267)
31. Martin GS. The road to src. Oncogene 2004;23:7910 -7917.
32. Poiesz BJ, Poiesz MJ, Choi D. The human T-cell lymphoma/leukemia viruses. Cancer Invest 2003;21:253-277. (Pubitemid 36532172)
33. Liu SL, Miller AD. Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein. Oncogene 2007;26:789-801. (Pubitemid 46245742)
34. Galateau-Salle F, Bidet P, Iwatsubo Y, et al. Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases. Dev Biol Stand 1998;94:147-152.
35. Giuliani L, Favalli C, Syrjanen K, Ciotti M. Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res 2007;27:2697-2704. (Pubitemid 47227985)
36. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007;99:1634-1643.
37. Cheng YW, Wu MF, Wang J, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007;67:10686-10693. (Pubitemid 350145894)
38. Limas C, Japaze H, Garcia-Bunuel R. "Scar" carcinoma of the lung. Chest 1971;59:219-222.
39. Bakris GL, Mulopulos GP, Korchik R, Ezdinli EZ, Ro J, Yoon BH. Pulmonary scar carcinoma. A clinicopathologic analysis. Cancer 1983; 52:493-497.
40. Yoneda K. Scar carcinomas of the lung in a histoplasmosis endemic area. Cancer 1990;65:164-168. (Pubitemid 20026828)
41. Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in gansu province, china. Int J Epidemiol 2001;30:118-124. (Pubitemid 32203799)
42. Ardies CM. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther 2003;2:238-246.
43. Knoop C, Haverich A, Fischer S. Immunosuppressive therapy after human lung transplantation. Eur Respir J 2004;23:159-171. (Pubitemid 38088513)
44. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the international society for heart and lung transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006;25:880-892. (Pubitemid 44143015)
45. Delgado M, Fernández R, Paradela M, et al. Development of neoplasms during lung transplantation follow-up. Transplant Proc 2008;40:3094-3096.
46. Cahill BC, Somerville KT, Crompton JA, et al. Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. J Heart Lung Transplant 2003;22:169-176.
47. Yakupoglu YK, Buell JF, Woodle S, Kahan BD. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc 2006;38:358-361.
48. Boratyńska M., Wa̧torek E., Smolska D., Patrzałek D, Klinger M. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies. Transplant Proc 2007;39:2736-2739. (Pubitemid 350088107)
49. Lopez V, Gutierrez C, Cabello M, Burgos D, Sola E, Gonzalez-Molina M. Conversion to sirolimus in posttransplant renal neoplasms. Transplant Proc 2007;39:2264-2266. (Pubitemid 47418164)
50. Sathy SJ, Martinu T, Youens K, et al. Symptomatic pulmonary allograft kaposi's sarcoma in two lung transplant recipients. Am J Transplant 2008;8:1951-1956.
51. Boffa DJ, Luan F, Thomas D, et al. Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res 2004;10:293-300. (Pubitemid 38114192)
52. Sanchez-Fructuoso A, Conesa J, Perez Flores I, et al. Conversion to sirolimus in renal transplant patients with tumors. Transplant Proc 2006;38:2451-2452. (Pubitemid 44693718)
53. Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152. (Pubitemid 41473051)
54. Low DE, Trulock EP, Kaiser LR, et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg 1992;103:1119-1126.
55. Bando K, Armitage JM, Paradis IL, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994;108:1056-1065. (Pubitemid 24379859)
56. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001;20:935-941.
57. Trulock EP, Christie JD, Edwards LB, et al. Registry of the international society for heart and lung transplantation: twenty-fourth official adult lung and Heart-Lung transplantation Report-2007. J Heart Lung Transplant 2007;26:782-795. (Pubitemid 47199080)
58. Schulman LL, Htun T, Staniloae C, McGregor CC, Austin JH. Pulmonary nodules and masses after lung and heart-lung transplantation. J Thorac Imaging 2000;15:173-179. (Pubitemid 30456997)
59. Lee P, Minai OA, Mehta AC, DeCamp MM, Murthy S. Pulmonarynodules in lung transplant recipients: etiology and outcome. Chest 2004;125:165-172. (Pubitemid 38114580)
60. McAdams HP, Erasmus JJ, Palmer SM. Complications (excluding hyperinflation) involving the native lung after single-lung transplantation: incidence, radiologic features, and clinical importance. Radiology 2001; 218:233-241.
61. End A, Helbich T, Wisser W, Dekan G, Klepetko W. The pulmonary nodule after lung transplantation: cause and outcome. Chest 1995;107: 1317-1322.
62. Rosenbaum DH, Bhojani RA, Dikmen E, et al. Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival. J Heart Lung Transplant 2005;24:2043-2047. (Pubitemid 41814722)
63. Bagan P, Assouad J, Berna P, Souilamas R, Le Pimpec Barthes F, Riquet M. Immediate and long-term survival after surgery for lung cancer in heart transplant recipients. Ann Thorac Surg 2005;79:438-442. (Pubitemid 40186533)
64. Jones HA, Donovan T, Goddard MJ, et al. Use of 18FDG-PET to discriminate between infection and rejection in lung transplant recipients. Transplantation 2004;77:1462-1464. (Pubitemid 38668446)
65. Marom EM, McAdams HP, Butnor KJ, Coleman RE. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. J Thorac Imaging 2004;19:74-78.
66. McCormack L, Hany TI, Hübner M, et al. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation? Am J Transplant 2006;6:1731-1736. (Pubitemid 43945817)
67. Laurent F, Latrabe V, Vergier B, Michel P. Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Intervent Radiol 2000;23:266-272. (Pubitemid 30740517)
68. Yousem SA, Paradis IL, Dauber JH, Griffith BP. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heartlung transplant recipients. Transplantation 1989;47:893-895.
69. Westcott JL, Rao N, Colley DP. Transthoracic needle biopsy of small pulmonary nodules. Radiology 1997;202:97-103. (Pubitemid 27024113)
70. Kazerooni EA, Hartker FW III, Whyte RI, Martinez FJ, Lynch JP. Transthoracic needle aspiration in patients with severe emphysema. A study of lung transplant candidates. Chest 1996;109:616-619.
71. Hopkins PM, Aboyoun CL, Chhajed PN, et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002;21:1062-1067.
72. Anyanwu AC, Townsend ER, Banner NR, Burke M, Khaghani A, Yacoub MH. Primary lung carcinoma after heart or lung transplantation: management and outcome. J Thorac Cardiovasc Surg 2002;124:1190-1197. (Pubitemid 35417007)
73. Self M, Dunn E, Cox J, Brinker K. Managing breast cancer in the renal transplant patient: a unique dilemma. Am Surg 2006;72:150-153. (Pubitemid 46940759)